Latest Insider Transactions at Stryve Foods, Inc. (SNAX)
This section provides a real-time view of insider transactions for Stryve Foods, Inc. (SNAX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of STRYVE FOODS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of STRYVE FOODS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 20
2024
|
Christopher J. Boever CEO |
BUY
Grant, award, or other acquisition
|
Direct |
84,261
+11.93%
|
-
|
Oct 04
2024
|
Kevin Vivian |
BUY
Grant, award, or other acquisition
|
Direct |
6,250
+20.22%
|
-
|
Sep 30
2024
|
Christopher J. Boever CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,435
-0.45%
|
$2,435
$1.46 P/Share
|
Sep 30
2024
|
Alex Hawkins CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
152
-0.13%
|
$152
$1.46 P/Share
|
Sep 15
2024
|
Alex Hawkins CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,217
-1.0%
|
$1,217
$1.49 P/Share
|
Sep 15
2024
|
Christopher J. Boever CEO |
BUY
Grant, award, or other acquisition
|
Direct |
243,633
+31.07%
|
-
|
Sep 15
2024
|
Christopher J. Boever CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
93,633
-23.98%
|
-
|
Sep 15
2024
|
Alex Hawkins CFO |
BUY
Grant, award, or other acquisition
|
Direct |
90,000
+42.52%
|
-
|
Sep 15
2024
|
Alex Hawkins CFO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
15,000
-32.15%
|
-
|
Jun 30
2024
|
Alex Hawkins CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
185
-0.39%
|
-
|
May 23
2024
|
Ted Casey |
BUY
Grant, award, or other acquisition
|
Direct |
16,500
+14.14%
|
-
|
May 23
2024
|
Mauricio Orellana |
BUY
Grant, award, or other acquisition
|
Direct |
5,500
+12.15%
|
-
|
May 23
2024
|
Gregory Stephen Christenson |
BUY
Grant, award, or other acquisition
|
Direct |
7,000
+13.12%
|
-
|
May 23
2024
|
Kevin Vivian |
BUY
Grant, award, or other acquisition
|
Direct |
5,500
+13.54%
|
-
|
May 23
2024
|
Robert D. Ramsey Iii |
BUY
Grant, award, or other acquisition
|
Direct |
5,500
+10.51%
|
-
|
May 23
2024
|
Chris Whitehair |
BUY
Grant, award, or other acquisition
|
Direct |
5,500
+25.09%
|
-
|
May 23
2024
|
B. Luke Weil |
BUY
Grant, award, or other acquisition
|
Direct |
7,000
+5.54%
|
-
|
Apr 10
2024
|
Alex Hawkins CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,483
-3.07%
|
-
|
Apr 09
2024
|
Alex Hawkins CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
350
-0.72%
|
-
|
Mar 21
2024
|
Christopher J. Boever CEO |
BUY
Grant, award, or other acquisition
|
Direct |
36,232
+8.49%
|
-
|
Dec 31
2023
|
Robert D. Ramsey Iii |
BUY
Grant, award, or other acquisition
|
Direct |
4,755
+20.32%
|
-
|
Dec 31
2023
|
Ted Casey |
BUY
Grant, award, or other acquisition
|
Direct |
2,717
+6.98%
|
-
|
Dec 31
2023
|
Alex Hawkins CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
152
-0.31%
|
-
|
Dec 31
2023
|
Chris Whitehair |
BUY
Grant, award, or other acquisition
|
Direct |
2,038
+33.27%
|
-
|
Dec 31
2023
|
B. Luke Weil |
BUY
Grant, award, or other acquisition
|
Direct |
5,434
+9.24%
|
-
|
Dec 31
2023
|
Kevin Vivian |
BUY
Grant, award, or other acquisition
|
Direct |
4,075
+23.98%
|
-
|
Dec 31
2023
|
Mauricio Orellana |
BUY
Grant, award, or other acquisition
|
Direct |
2,717
+15.18%
|
-
|
Dec 31
2023
|
Gregory Stephen Christenson |
BUY
Grant, award, or other acquisition
|
Direct |
5,434
+23.96%
|
-
|
Dec 28
2023
|
Alex Hawkins CFO |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+24.79%
|
-
|
Dec 28
2023
|
Christopher J. Boever CEO |
BUY
Grant, award, or other acquisition
|
Direct |
93,633
+12.11%
|
-
|
Dec 28
2023
|
Christopher J. Boever CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
63,333
-19.55%
|
-
|
Dec 13
2023
|
Christopher J. Boever CEO |
BUY
Open market or private purchase
|
Direct |
3,000
+0.92%
|
$6,000
$2.35 P/Share
|
Dec 12
2023
|
Christopher J. Boever CEO |
BUY
Open market or private purchase
|
Direct |
1,250
+0.19%
|
$2,500
$2.29 P/Share
|
Dec 01
2023
|
Christopher J. Boever CEO |
BUY
Open market or private purchase
|
Direct |
3,500
+1.08%
|
$7,000
$2.87 P/Share
|
Nov 24
2023
|
Christopher J. Boever CEO |
BUY
Open market or private purchase
|
Direct |
2,500
+0.78%
|
$7,500
$3.03 P/Share
|
Nov 22
2023
|
Christopher J. Boever CEO |
BUY
Open market or private purchase
|
Direct |
4,000
+1.26%
|
$8,000
$2.98 P/Share
|
Nov 21
2023
|
Christopher J. Boever CEO |
BUY
Open market or private purchase
|
Direct |
4,000
+1.28%
|
$8,000
$2.97 P/Share
|
Nov 20
2023
|
Christopher J. Boever CEO |
BUY
Open market or private purchase
|
Direct |
5,000
+1.61%
|
$15,000
$3.11 P/Share
|
Nov 17
2023
|
Christopher J. Boever CEO |
BUY
Open market or private purchase
|
Direct |
4,750
+1.56%
|
$14,250
$3.03 P/Share
|
Sep 30
2023
|
Alex Hawkins CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
147
-0.3%
|
-
|
Sep 30
2023
|
Ted Casey |
BUY
Grant, award, or other acquisition
|
Direct |
1,448
+0.3%
|
-
|
Sep 30
2023
|
Kevin Vivian |
BUY
Grant, award, or other acquisition
|
Direct |
2,171
+2.08%
|
-
|
Sep 30
2023
|
Robert D. Ramsey Iii |
BUY
Grant, award, or other acquisition
|
Direct |
2,895
+1.7%
|
-
|
Sep 30
2023
|
Gregory Stephen Christenson |
BUY
Grant, award, or other acquisition
|
Direct |
2,895
+2.07%
|
-
|
Sep 30
2023
|
Chris Whitehair |
BUY
Grant, award, or other acquisition
|
Direct |
724
+3.39%
|
-
|
Sep 30
2023
|
B. Luke Weil |
BUY
Grant, award, or other acquisition
|
Direct |
2,895
+0.42%
|
-
|
Sep 30
2023
|
Mauricio Orellana |
BUY
Grant, award, or other acquisition
|
Direct |
1,448
+0.86%
|
-
|
Sep 13
2023
|
Christopher J. Boever CEO |
BUY
Open market or private purchase
|
Direct |
6,600
+1.11%
|
$19,800
$3.71 P/Share
|
Sep 08
2023
|
Christopher J. Boever CEO |
BUY
Open market or private purchase
|
Direct |
1,960
+0.67%
|
$5,880
$3.93 P/Share
|
Sep 07
2023
|
Christopher J. Boever CEO |
BUY
Open market or private purchase
|
Direct |
2,200
+0.76%
|
$8,800
$4.04 P/Share
|